Reconstruction of the hand in Apert syndrome: two case reports and a literature review of updated strategies for diagnosis and management.

BACKGROUND: Apert syndrome is a set of complex malformations of the first brachial arch, with manifestations on the skull, face, hands and feet. At the level of the hand, the following signs are always present: complex syndactyly of the second, third and fourth digits with distal bone fusion; simple syndactyly of the fifth digit; foreshortened thumb with radial clinodactily; and symphalangism excluding the fifth digit. METHODS: The digital separation of an Apert hand should begin at 9 months of age and should be completed by 2 to 4 years of age. Our simplified approach consists of early bilateral surgery on border digits followed by unilateral separation of middle syndactily combined with thumb and digit osteotomies and bone grafting as required. RESULTS: Between 1995 and 2010 seven patients with Apert syndrome underwent reconstructive surgery of the complex hand syndactyly. The main target in our surgical strategy involved early bilateral separation of border digits, which started between 1 and 2 years of age. The unilateral middle syndactyly mass division with osteotomy of the thumb and other digits and bone grafting (as required) was carried out in later surgeries, which are usually completed by 4 years of age. The evaluation of the results was performed based on the functional results of the hand, morbidity, flap necrosis, skin graft lysis, postoperative range of motion in the small joints, gross grasp, pincer grasp, scar appearance, contractures of digits, and aesthetic outcome. CONCLUSION: As intended, this study proves the need for a complex surgical approach as early as possible with low revision rate, and acceptable functional and aesthetic outcome.

Accessory parotid gland tumours: 24 years of clinical experience.

The accessory parotid gland (APG) is salivary tissue anterior to and anatomically separate from the parotid gland. APG is a common anatomical variation, but APG tumours are extremely rare. The authors report 6 patients with APG tumours emphasizing the diagnosis, clinical features, indications and rationales for different treatment approaches. Patients with primary tumours of the parotid gland or APG tumours who underwent surgical treatment were included. APG tumours comprised 1.23% of overall parotid tumours (6/488) and had a malignancy rate of 33.3% (2/6). There were three male and three female patients with a mean age of 39 years (range 14-70 years). 5 of 6 parotidectomies entailed superficial lobectomy, while one was a total parotidectomy with composite resection of masseter muscle. Concomitant selective lymphadenectomy was carried out in 3 of 6 patients. At 5 years disease-free survival was 83.3%. Mean follow-up was 161 months (range 14-253 months). Although nonsalivary diagnoses frequently occur in the buccal area, APG tumours should be considered in every differential diagnosis in patients presenting with a mid-cheek mass. From oncosurgical, cosmetic and functional standpoints, treatment by facelift parotidectomy or 'S-incision' with concomitant superficial lobectomy is the recommended surgical approach; high-grade malignancies require total parotidectomy with regional lymphadenectomy.